These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20062715)

  • 1. Thromboembolic complications of intravenous immunoglobulin (IVIG) in an immunocompromised patient with Chronic Lymphocytic Leukemia: a case report.
    Milani C; Dalia SM; Colvin GA
    Cases J; 2009 Nov; 2():9078. PubMed ID: 20062715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulins for rheumatic disorders and thromboembolic events-a case series and review of the literature.
    Lidar M; Masarwa S; Rotman P; Carmi O; Rabinowicz N; Levy Y
    Immunol Res; 2018 Dec; 66(6):668-674. PubMed ID: 30565202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections.
    Günther G; Dreger B
    Microbiol Immunol; 2013 Jul; 57(7):527-35. PubMed ID: 23607863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of intravenous immunoglobulin (IVIG) therapy.
    Katz U; Achiron A; Sherer Y; Shoenfeld Y
    Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin: adverse effects and safe administration.
    Orbach H; Katz U; Sherer Y; Shoenfeld Y
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):173-84. PubMed ID: 16391392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal infarction associated with low dose intravenous immunoglobulin in a kidney transplant recipient with sepsis: a case report and literature review.
    Choi EW; Do JY; Kim AY; Kang SH
    BMC Nephrol; 2021 Oct; 22(1):338. PubMed ID: 34645393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.
    Marie I; Maurey G; Hervé F; Hellot MF; Levesque H
    Br J Dermatol; 2006 Oct; 155(4):714-21. PubMed ID: 16965420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study.
    Molica S; Musto P; Chiurazzi F; Specchia G; Brugiatelli M; Cicoira L; Levato D; Nobile F; Carotenuto M; Liso V; Rotoli B
    Haematologica; 1996; 81(2):121-6. PubMed ID: 8641639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial infarction during intravenous immunoglobulin infusion in a 65-year-old man with common variable immunodeficiency and subsequent successful repeated administration.
    Davé S; Hagan J
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):567-70. PubMed ID: 18219840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Canadian perspective on the use of immunoglobulin therapy to reduce infectious complications in chronic lymphocytic leukemia.
    Lachance S; Christofides AL; Lee JK; Sehn LH; Ritchie BC; Shustik C; Stewart DA; Toze CL; Haddad E; Vinh DC
    Curr Oncol; 2016 Feb; 23(1):42-51. PubMed ID: 26966403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Lasting SARS-CoV-2 Infection With Post-COVID-19 Chronic Interstitial Pneumonia in a Patient With Chronic Lymphocytic Leukemia Treated Successfully With Intravenous Immunoglobulin.
    Haddad A; Al-Maharmeh Q; Kloub MN; Ali EA; Shaaban H
    Cureus; 2024 Jan; 16(1):e51890. PubMed ID: 38333462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events.
    Dalakas MC
    Neurology; 1994 Feb; 44(2):223-6. PubMed ID: 8309562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era.
    Baek DW; Song GY; Lee HS; Do YR; Lee JH; Yhim HY; Moon JH; Yang DH
    Front Oncol; 2024; 14():1380492. PubMed ID: 38715775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-control study of thromboembolic events associated with IV immunoglobulin.
    Caress JB; Hobson-Webb L; Passmore LV; Finkbiner AP; Cartwright MS
    J Neurol; 2009 Mar; 256(3):339-42. PubMed ID: 19253011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolic complications of intravenous immunoglobulin treatment.
    Vucic S; Chong PS; Dawson KT; Cudkowicz M; Cros D
    Eur Neurol; 2004; 52(3):141-4. PubMed ID: 15479982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Not all intravenous immunoglobulin preparations are equally well tolerated.
    Feldmeyer L; Benden C; Haile SR; Boehler A; Speich R; French LE; Hofbauer GF
    Acta Derm Venereol; 2010 Sep; 90(5):494-7. PubMed ID: 20814625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: intravenous immunoglobulin therapy and thromboembolic complications.
    Katz U; Shoenfeld Y
    Lupus; 2005; 14(10):802-8. PubMed ID: 16302674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of thromboembolic risk related to high-dose intravenous immunoglobulin treatment: a preliminary clinical study of 10 patients with autoimmune mucocutaneous blistering diseases.
    Mignogna MD; Fortuna G; Leuci S; Ruoppo E; Adamo D; Fedele S
    Clin Exp Dermatol; 2009 Mar; 34(2):145-50. PubMed ID: 19187294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
    Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary spastic angina after the administration of intravenous immunoglobulin in myasthenia gravis: a case report.
    Yanagihashi M; Okamoto R; Morioka H; Sawada M; Matsumoto S; Ikeda T; Kano O
    BMC Neurol; 2020 Aug; 20(1):319. PubMed ID: 32859168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.